Skip to main content
Top
Published in: Clinical Oral Investigations 3/2008

01-09-2008 | Original Article

Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of human infrabony defects

Authors: Adrian Kasaj, Bernd Röhrig, Christoph Reichert, Brita Willershausen

Published in: Clinical Oral Investigations | Issue 3/2008

Login to get access

Abstract

The purpose of the present study was to compare the clinical outcomes of infrabony periodontal defects following treatment with an anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (ABM/P-15) flow to open flap debridement. Twenty-six patients, each displaying one infrabony defect with probing depth ≥6 mm and vertical radiographic bone loss ≥3 mm participated in the present study. Patients were allocated randomly to be treated with ABM/P-15 flow (test group) or open flap debridement (control group). At baseline and at 12 months after surgery, the following clinical parameters were recorded by a blinded examiner: plaque index, gingival index, probing depth (PD), clinical attachment level (CAL), and gingival recession. Both treatments resulted in significant improvements between baseline and 12 months, in terms of PD reduction and CAL gain (p < 0.001). At 12 months following therapy, the test group showed a reduction in mean PD from 7.8 ± 1.6 mm to 3.5 ± 1.0 mm and a change in mean CAL from 8.5 ± 2.1 mm to 4.6 ± 1.2 mm, whereas in the control group the mean PD decreased from 7.5 ± 0.8 mm to 4.9 ± 0.7 mm and mean CAL from 8.2 ± 1.2 mm to 6.4 ± 1.4 mm. The test group demonstrated significantly greater PD reductions (p = 0.002) and CAL gains (p = 0.001) compared to the control group. In conclusion, treatment of infrabony periodontal defects with ABM/P-15 flow significantly improved clinical outcomes compared to open flap debridement.
Literature
1.
go back to reference Barros RR, Novaes AB Jr, Roriz VM, Oliveira RR, Grisi MF, Souza SL, Taba M Jr, Palioto DB (2006) Anorganic bovine matrix/P-15 “flow” in the treatment of periodontal defects: case series with 12 months of follow-up. J Periodontol 77:1280–1287PubMedCrossRef Barros RR, Novaes AB Jr, Roriz VM, Oliveira RR, Grisi MF, Souza SL, Taba M Jr, Palioto DB (2006) Anorganic bovine matrix/P-15 “flow” in the treatment of periodontal defects: case series with 12 months of follow-up. J Periodontol 77:1280–1287PubMedCrossRef
2.
go back to reference Bhatnagar RS, Qian JJ, Gough CA (1997) The role in cell binding of a beta-bend within the triple helical region in collagen a1 (I) chain: structural and biological evidence for conformation tautomerism on fiber surface. J Biomol Struct Dyn 14:547–560PubMed Bhatnagar RS, Qian JJ, Gough CA (1997) The role in cell binding of a beta-bend within the triple helical region in collagen a1 (I) chain: structural and biological evidence for conformation tautomerism on fiber surface. J Biomol Struct Dyn 14:547–560PubMed
3.
go back to reference Bhatnagar RS, Qian JJ, Wedrychowska AW, Sadeghi M, Wu YM, Smith N (1999) Design of biometric habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 5:53–65PubMedCrossRef Bhatnagar RS, Qian JJ, Wedrychowska AW, Sadeghi M, Wu YM, Smith N (1999) Design of biometric habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 5:53–65PubMedCrossRef
4.
go back to reference Caffesse RG, Kerry GJ, Chaves ES, McLean TN, Morrison EC, Lopatin DE, Caffesse ER, Stults DL (1988) Clinical evaluation of the use of citric acid and autologous fibronectin in periodontal surgery. J Periodontol 59:565–569PubMed Caffesse RG, Kerry GJ, Chaves ES, McLean TN, Morrison EC, Lopatin DE, Caffesse ER, Stults DL (1988) Clinical evaluation of the use of citric acid and autologous fibronectin in periodontal surgery. J Periodontol 59:565–569PubMed
5.
go back to reference Camargo PM, Lekovic V, Weinlaender M, Nedic M, Vasilic N, Wolinsky LE, Kenney EB (2000) A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans. J Clin Periodontol 27:889–896PubMedCrossRef Camargo PM, Lekovic V, Weinlaender M, Nedic M, Vasilic N, Wolinsky LE, Kenney EB (2000) A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans. J Clin Periodontol 27:889–896PubMedCrossRef
6.
go back to reference Cortellini P, Carnevale G, Sanz M, Tonetti MS (1998) Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 25:981–987PubMedCrossRef Cortellini P, Carnevale G, Sanz M, Tonetti MS (1998) Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 25:981–987PubMedCrossRef
7.
go back to reference DeSanctis M, Clauser C, Zucchelli G (1996) Bacterial colonization of resorbable barrier materials and periodontal regeneration. J Periodontol 67:1193–1200 DeSanctis M, Clauser C, Zucchelli G (1996) Bacterial colonization of resorbable barrier materials and periodontal regeneration. J Periodontol 67:1193–1200
8.
go back to reference Eto AL, Joly JC, Jeffcoat M, de Araujo NS, de Araujo VC, Cury PR (2007) Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans. J Periodontol 78:2277–2283PubMedCrossRef Eto AL, Joly JC, Jeffcoat M, de Araujo NS, de Araujo VC, Cury PR (2007) Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of class II furcation defects: a clinical and radiographic study in humans. J Periodontol 78:2277–2283PubMedCrossRef
9.
go back to reference Froum SJ, Coran M, Thaller B, Kushner L, Scopp IW, Stahl SS (1982) Periodontal healing following open debridement flap procedures. J Periodontol 53:8–14PubMed Froum SJ, Coran M, Thaller B, Kushner L, Scopp IW, Stahl SS (1982) Periodontal healing following open debridement flap procedures. J Periodontol 53:8–14PubMed
10.
go back to reference Froum SJ, Kushnek L, Scopp IW, Stahl SS (1982) Human clinical and histologic responses to durapatite in intraosseous lesions. Case reports. J Periodontol 53:719–729PubMed Froum SJ, Kushnek L, Scopp IW, Stahl SS (1982) Human clinical and histologic responses to durapatite in intraosseous lesions. Case reports. J Periodontol 53:719–729PubMed
11.
go back to reference Goldman HM, Cohen DW (1958) The infrabony pocket: classification and treatment. J Periodontol 29:272–291 Goldman HM, Cohen DW (1958) The infrabony pocket: classification and treatment. J Periodontol 29:272–291
12.
go back to reference Gottlow J, Nyman S, Lindhe J, Karring T, Wennstrom J (1986) New attachment formation in the human periodontium by guided tissue regeneration. J Clin Periodontol 13:604–616PubMedCrossRef Gottlow J, Nyman S, Lindhe J, Karring T, Wennstrom J (1986) New attachment formation in the human periodontium by guided tissue regeneration. J Clin Periodontol 13:604–616PubMedCrossRef
13.
go back to reference Klein F, Kim TS, Hassfeld S, Staehle HJ, Reitmeier P, Holle R, Eickholz P (2001) Radiographic defect depth and width for prognosis and description of periodontal healing of infrabony defects. J Periodontol 72:1639–1646PubMedCrossRef Klein F, Kim TS, Hassfeld S, Staehle HJ, Reitmeier P, Holle R, Eickholz P (2001) Radiographic defect depth and width for prognosis and description of periodontal healing of infrabony defects. J Periodontol 72:1639–1646PubMedCrossRef
14.
go back to reference Lang NK (2000) Focus on intrabony defects—conservative therapy. Periodontol 22:51–58CrossRef Lang NK (2000) Focus on intrabony defects—conservative therapy. Periodontol 22:51–58CrossRef
15.
go back to reference Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Djordjevic M, Kenney EB (2001) The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony defects in humans. J Periodontol 72:1157–1163PubMedCrossRef Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Djordjevic M, Kenney EB (2001) The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony defects in humans. J Periodontol 72:1157–1163PubMedCrossRef
16.
go back to reference Liñares A, Cortellini P, Lang NP, Suvan J, Tonetti MS (2006) Guided tissue regenration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: Radiographic predictors and outcomes. J Clin Periodontol 33:351–352PubMedCrossRef Liñares A, Cortellini P, Lang NP, Suvan J, Tonetti MS (2006) Guided tissue regenration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: Radiographic predictors and outcomes. J Clin Periodontol 33:351–352PubMedCrossRef
17.
go back to reference Löe H (1967) The gingival index, the plaque index, and the retention index systems. J Periodontol 38:610–616PubMed Löe H (1967) The gingival index, the plaque index, and the retention index systems. J Periodontol 38:610–616PubMed
18.
go back to reference Lynch SE, Williams RC, Polson AM (1989) A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 16:545–548PubMedCrossRef Lynch SE, Williams RC, Polson AM (1989) A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 16:545–548PubMedCrossRef
19.
go back to reference Matos SM, Guerra FA, Krauser J, Marques F, Ermida JM, Sanz M (2007) Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study. J Periodontol 78:1855–1863PubMedCrossRef Matos SM, Guerra FA, Krauser J, Marques F, Ermida JM, Sanz M (2007) Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study. J Periodontol 78:1855–1863PubMedCrossRef
20.
go back to reference Meffert RM, Thomas JR, Hamilton KM, Brownstein CN (1985) Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol 56:63–73PubMed Meffert RM, Thomas JR, Hamilton KM, Brownstein CN (1985) Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol 56:63–73PubMed
21.
go back to reference Mellonig JT, Bowers GM, Cotton WR (1981) Comparison of bone graft materials. J Periodontol 52:297–301PubMed Mellonig JT, Bowers GM, Cotton WR (1981) Comparison of bone graft materials. J Periodontol 52:297–301PubMed
22.
go back to reference Nyman S, Lindhe J, Karring T, Rylander H (1982) New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 9:260–269 Nyman S, Lindhe J, Karring T, Rylander H (1982) New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 9:260–269
23.
go back to reference Nyman S, Lindhe J, Rosling B (1977) Periodontal surgery in plaque infected dentitions. J Clin Periodontol 4:240–249PubMedCrossRef Nyman S, Lindhe J, Rosling B (1977) Periodontal surgery in plaque infected dentitions. J Clin Periodontol 4:240–249PubMedCrossRef
24.
go back to reference Park JS, Suh JJ, Choi SH, Moon IS, Cho KS, Kim CK, Chai JK (2001) Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 72:730–740PubMedCrossRef Park JS, Suh JJ, Choi SH, Moon IS, Cho KS, Kim CK, Chai JK (2001) Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 72:730–740PubMedCrossRef
25.
go back to reference Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840PubMedCrossRef Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840PubMedCrossRef
26.
go back to reference Qian JJ, Bhatnagar RS (1996) Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 31:545–554PubMedCrossRef Qian JJ, Bhatnagar RS (1996) Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 31:545–554PubMedCrossRef
27.
go back to reference Quteish D, Dolby A (1992) The use of irradiated-crosslinked human collagen membrane in guided tissue regeneration. J Clin Periodontol 19:476–484PubMedCrossRef Quteish D, Dolby A (1992) The use of irradiated-crosslinked human collagen membrane in guided tissue regeneration. J Clin Periodontol 19:476–484PubMedCrossRef
28.
go back to reference Rabalais ML, Yukna RA, Mayer ET (1981) Evaluation of durapatite ceramic as an alloplast implant in periodontal osseous defects. Initial six-month results. J Periodontol 52:680–689PubMed Rabalais ML, Yukna RA, Mayer ET (1981) Evaluation of durapatite ceramic as an alloplast implant in periodontal osseous defects. Initial six-month results. J Periodontol 52:680–689PubMed
29.
go back to reference Richardson CR, Mellonig JT, Brunsvold MA, McDonnel HT, Cochran DL (1999) Clinical evaluation of Bio-Oss: a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 26:421–428PubMedCrossRef Richardson CR, Mellonig JT, Brunsvold MA, McDonnel HT, Cochran DL (1999) Clinical evaluation of Bio-Oss: a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 26:421–428PubMedCrossRef
30.
go back to reference Rosling B, Nyman S, Lindhe J (1976) The effect of systematic plaque control on bone regeneration in infrabony pockets. J Clin Periodontol 3:38–53PubMedCrossRef Rosling B, Nyman S, Lindhe J (1976) The effect of systematic plaque control on bone regeneration in infrabony pockets. J Clin Periodontol 3:38–53PubMedCrossRef
31.
go back to reference Sapkos SW (1986) The use of periograft in periodontal defects. Histologic findings. J Periodontol 57:7–13PubMed Sapkos SW (1986) The use of periograft in periodontal defects. Histologic findings. J Periodontol 57:7–13PubMed
32.
go back to reference Scarano A, Iezzi G, Petrone G, Orsini G, Degidi M, Strocchi R, Piattelli A (2003) Cortical bone regeneration with a synthetic cell-binding peptide: a histologic and histomorphometric pilot study. Implant Dent 12:318–32PubMedCrossRef Scarano A, Iezzi G, Petrone G, Orsini G, Degidi M, Strocchi R, Piattelli A (2003) Cortical bone regeneration with a synthetic cell-binding peptide: a histologic and histomorphometric pilot study. Implant Dent 12:318–32PubMedCrossRef
33.
go back to reference Sculean A, Berakdar M, Chiantella GC, Donos N, Arweiler NB, Brecx M (2003) Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. J Clin Periodontol 30:73–80PubMedCrossRef Sculean A, Berakdar M, Chiantella GC, Donos N, Arweiler NB, Brecx M (2003) Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. J Clin Periodontol 30:73–80PubMedCrossRef
34.
go back to reference Selvig KA, Kersten BG, Chamberlain AD, Wikesjo UM, Nilveus RE (1992) Regenerative surgery of intrabony defects using ePTFE barrier membranes. Scanning electron microscopic evaluation of retrieved membranes versus clinical healing. J Periodontol 63:974–978PubMed Selvig KA, Kersten BG, Chamberlain AD, Wikesjo UM, Nilveus RE (1992) Regenerative surgery of intrabony defects using ePTFE barrier membranes. Scanning electron microscopic evaluation of retrieved membranes versus clinical healing. J Periodontol 63:974–978PubMed
35.
go back to reference Seyedin SM (1989) Osteoinduction: a report on the discovery and research of unique protein growth factors mediating bone development. Oral Surg Oral Med Oral Pathol 68:527–530PubMedCrossRef Seyedin SM (1989) Osteoinduction: a report on the discovery and research of unique protein growth factors mediating bone development. Oral Surg Oral Med Oral Pathol 68:527–530PubMedCrossRef
36.
go back to reference Stahl SS, Froum SJ (1987) Histologic and clinical responses to porous hydroxylapatite implants in human periodontal defects. Three to twelve months postimplantation. J Periodontol 58:689–695PubMed Stahl SS, Froum SJ (1987) Histologic and clinical responses to porous hydroxylapatite implants in human periodontal defects. Three to twelve months postimplantation. J Periodontol 58:689–695PubMed
37.
go back to reference Tonetti MS, Cortellini P, Lang NP, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Rasperini G, Rossi R, Silvestri M, Topoll H, Wallkamm B, Zybutz M (2004) Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomised controlled clinical trial. J Clin Periodontol 31:770–776PubMedCrossRef Tonetti MS, Cortellini P, Lang NP, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Rasperini G, Rossi R, Silvestri M, Topoll H, Wallkamm B, Zybutz M (2004) Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomised controlled clinical trial. J Clin Periodontol 31:770–776PubMedCrossRef
38.
go back to reference Tonetti MS, Pini-Prato G, Cortellini P (1993) Periodontal regeneration of human infrabony defects. IV. Determinants of the healing response. J Periodontol 64:934–940PubMed Tonetti MS, Pini-Prato G, Cortellini P (1993) Periodontal regeneration of human infrabony defects. IV. Determinants of the healing response. J Periodontol 64:934–940PubMed
39.
go back to reference Tonetti MS, Pini-Prato G, Cortellini P (1995) Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 22:229–234PubMedCrossRef Tonetti MS, Pini-Prato G, Cortellini P (1995) Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 22:229–234PubMedCrossRef
40.
go back to reference Tonetti MS, Pini-Prato G, Cortellini P (1996) Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 23:548–556PubMedCrossRef Tonetti MS, Pini-Prato G, Cortellini P (1996) Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 23:548–556PubMedCrossRef
41.
go back to reference Trombelli L, Heitz-Mayfield L, Needleman I, Moles D, Scabbia A (2002) A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol 29:117–135PubMedCrossRef Trombelli L, Heitz-Mayfield L, Needleman I, Moles D, Scabbia A (2002) A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol 29:117–135PubMedCrossRef
42.
go back to reference Tsitoura E, Tucker R, Suvan J, Laurell L, Cortellini P, Tonetti M (2004) Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative. J Clin Periodontol 31:643–647PubMedCrossRef Tsitoura E, Tucker R, Suvan J, Laurell L, Cortellini P, Tonetti M (2004) Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative. J Clin Periodontol 31:643–647PubMedCrossRef
43.
go back to reference Vastardis S, Yukna RA, Mayer ET, Atkinson BL (2005) Periodontal regeneration with peptide-enhanced anorganic bone matrix in particulate and putty form in dogs. J Periodontol 76:1690–1696PubMedCrossRef Vastardis S, Yukna RA, Mayer ET, Atkinson BL (2005) Periodontal regeneration with peptide-enhanced anorganic bone matrix in particulate and putty form in dogs. J Periodontol 76:1690–1696PubMedCrossRef
44.
go back to reference Yukna RA (1989) Osseous defect responses to hydroxylapatite grafting versus open flap debridement. J Clin Periodontol 16:389–402CrossRef Yukna RA (1989) Osseous defect responses to hydroxylapatite grafting versus open flap debridement. J Clin Periodontol 16:389–402CrossRef
45.
go back to reference Yukna RA (1993) Synthetic bone grafts in periodontics. Periodontol 2000 1:92–99CrossRef Yukna RA (1993) Synthetic bone grafts in periodontics. Periodontol 2000 1:92–99CrossRef
46.
go back to reference Yukna RA, Callan DP, Krauser JT, Evans GH, Aichelmann-Reidy ME, Moore K, Cruz R, Scott JB (1998) Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-Month results. J Periodontol 69:655–663PubMed Yukna RA, Callan DP, Krauser JT, Evans GH, Aichelmann-Reidy ME, Moore K, Cruz R, Scott JB (1998) Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-Month results. J Periodontol 69:655–663PubMed
47.
go back to reference Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M (2000) Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. Six-month results. J Periodontol 71:1671–1679PubMedCrossRef Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M (2000) Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. Six-month results. J Periodontol 71:1671–1679PubMedCrossRef
48.
go back to reference Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M (2002) Thirty-six months follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) bone replacement grafts in human intrabony defects. I. Clinical findings. J Periodontol 73:123–128PubMedCrossRef Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M (2002) Thirty-six months follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) bone replacement grafts in human intrabony defects. I. Clinical findings. J Periodontol 73:123–128PubMedCrossRef
49.
go back to reference Yukna RA, Salinas TJ, Carr RF (2002) Periodontal regeneration following use of ABM/P-15: a case report. Int J Periodontics Restorative Dent 22:146–155PubMed Yukna RA, Salinas TJ, Carr RF (2002) Periodontal regeneration following use of ABM/P-15: a case report. Int J Periodontics Restorative Dent 22:146–155PubMed
Metadata
Title
Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of human infrabony defects
Authors
Adrian Kasaj
Bernd Röhrig
Christoph Reichert
Brita Willershausen
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Clinical Oral Investigations / Issue 3/2008
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-008-0191-y

Other articles of this Issue 3/2008

Clinical Oral Investigations 3/2008 Go to the issue